Meet Aikido Pharma Inc’s Board of Directors

Aikido Pharma Inc is a biotechnology development company working to develop a diverse portfolio of early and mid-stage small-molecule anti-cancer therapeutics. Our diverse pipeline of therapeutics includes therapies for prostate, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL). Our prostate and pancreatic treatment has shown positive preclinical results. For more information, get in touch with Aikido Pharma Inc by calling us at 212-745-1373.  

Robert J. Vander Zanden, Ph.D.
Dr. Robert J. Vander Zanden, Board Member since 2004, was elected Chairman of the Board in early 2009.

Tim Ledwick
Mr. Ledwick is currently the Chief Financial Officer of Management Health Solutions, a private equity-backed company that provides software solutions and services to hospitals focused on reducing costs through superior inventory management practices.

Greg Blattner
Greg Blattner is a Director at Agio, a progressive Managed IT and Cybersecurity Cervices Provider.

Anthony C. Hayes, Esq.
Anthony C. Hayes is the CEO of Aikido Pharma Inc., a NASDAQ-traded (ticker: AIKI) technology commercialization company.

Paul LeMire
Paul LeMire is a Managing Director of Day Hagan Asset Management where he is responsible for National Sales and Distribution.

Robert Dudley
Robert Dudley is the Eastern Division and Metropolitan NYC Regional Sales Manager for Select Sector SPDRs. *